We are live on ! Find out more
GC

Grace Capital Portfolio holdings

AUM $168M
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
AUM
$256M
AUM Growth
-$6.25M
Cap. Flow
-$17.3M
Cap. Flow %
-6.78%
Top 10 Hldgs %
27.99%
Holding
234
New
14
Increased
21
Reduced
87
Closed
27

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$9.46M
2
AMZN icon
Amazon
AMZN
+$2.46M
3
RMD icon
ResMed
RMD
+$1.94M
4
SONY icon
Sony
SONY
+$1.42M
5
ACN icon
Accenture
ACN
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 20.63%
2 Healthcare 20.01%
3 Financials 13.97%
4 Consumer Discretionary 10.11%
5 Energy 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
176
Danaher
DHR
$135B
$109K 0.04%
1,128
WAT icon
177
Waters Corp
WAT
$36.8B
$97K 0.04%
500
NSC icon
178
Norfolk Southern
NSC
$78.8B
$90K 0.04%
500
JAZZ icon
179
Jazz Pharmaceuticals
JAZZ
$15.9B
$84K 0.03%
500
PX
180
DELISTED
Praxair Inc
PX
$80K 0.03%
500
MPLX icon
181
MPLX
MPLX
$59.5B
$79K 0.03%
2,289
PEP icon
182
PepsiCo
PEP
$186B
$73K 0.03%
650
SLB icon
183
SLB Ltd
SLB
$77.8B
$73K 0.03%
1,200
CELG
184
DELISTED
Celgene Corp
CELG
$72K 0.03%
800
KO icon
185
Coca-Cola
KO
$354B
$70K 0.03%
1,520
BC icon
186
Brunswick
BC
$5.19B
$67K 0.03%
1,000
-5,000
-83% -$331K
EBAY icon
187
eBay
EBAY
$48.6B
$66K 0.03%
2,000
DOC icon
188
Healthpeak Properties
DOC
$15.4B
$65K 0.03%
2,476
EMQQ icon
189
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$258M
$64K 0.03%
2,000
-7,163
-78% -$244K
CVX icon
190
Chevron
CVX
$388B
$61K 0.02%
500
CL icon
191
Colgate-Palmolive
CL
$72.6B
$60K 0.02%
900
RDY icon
192
Dr. Reddy's Laboratories
RDY
$9.82B
$52K 0.02%
7,500
+2,500
+50% +$16.7K
EQT icon
193
EQT Corp
EQT
$33.2B
$46K 0.02%
1,929
FTV icon
194
Fortive
FTV
$19B
$42K 0.02%
793
XLE icon
195
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$38K 0.01%
1,000
CTMX icon
196
CytomX Therapeutics
CTMX
$705M
$35K 0.01%
+1,888
New +$43K
TEVA icon
197
Teva Pharmaceuticals
TEVA
$35.9B
$32K 0.01%
1,500
GERN icon
198
Geron
GERN
$911M
$28K 0.01%
16,000
DGRO icon
199
iShares Core Dividend Growth ETF
DGRO
$42.6B
$27K 0.01%
730
ATI icon
200
ATI
ATI
$27B
$24K 0.01%
800

Similar funds

Grace Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Grace Capital held 234 positions worth $256M, down 2.4% from $262M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grace Capital withdrew a net $17.3M in Q3 2018, closing 27 positions and reducing 87 holdings. Its most notable exit was Red Hat Inc, an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grace Capital opened a new position in ResMed worth $2.04M.

  • Grace Capital's largest Q3 2018 buy was ResMed: 17,720 shares worth $2.04M.
  • Grace Capital added most to Global Blood Therapeutics, Inc. in Q3 2018, an estimated $9.46M increase.
  • Grace Capital's biggest Q3 2018 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $3.29M.
  • Grace Capital fully exited Red Hat Inc in Q3 2018, selling an estimated $1.6M.
  • Grace Capital's ten largest holdings make up 28% of its $256M portfolio in Q3 2018.
  • Grace Capital opened 14 new positions and closed 27 in Q3 2018.
  • Grace Capital's portfolio value fell 2.4% quarter-over-quarter to $256M.

Based on Grace Capital's 13F filing for Q3 2018, filed 14 Nov 2018.